GSK NEXT
GSK NEXT is the strategic commercial growth engine for GSK Consumer Healthcare, focused on the creation and scaling of net-new product, service and platform businesses across everyday health.
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-16 | Bristle | GSK NEXT investment in Non Equity Assistance - Bristle | N/A |
| 2021-11-16 | Patientory | GSK NEXT investment in Seed Round - Patientory | N/A |
| 2021-11-16 | Smilo.AI | GSK NEXT investment in Non Equity Assistance - Smilo.AI | N/A |
| 2021-11-16 | Health In Her HUE | GSK NEXT investment in Non Equity Assistance - Health In Her HUE | N/A |
| 2021-11-16 | nQ Medical | GSK NEXT investment in Seed Round - nQ Medical | N/A |
| 2021-11-16 | Unfabled | GSK NEXT investment in Non Equity Assistance - Unfabled | N/A |
More informations about "GSK NEXT"
Purpose, strategy and culture | GSK Canada
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years.See details»
GSK NEXT Launches The Re/Wire Health Studio With R/GA …
Aug 17, 2021 GSK NEXT is the strategic commercial growth engine for GSK Consumer Healthcare, focused on the creation and scaling of net-new product, service and platform …See details»
Canada leadership team - GSK
Trademarks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. GlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1 > GSK Modern Slavery …See details»
Board of directors and leadership team - GSK
Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act statement …See details»
GSK Canada unveils new head office, embracing a hybrid working …
Jun 15, 2022 The opening of GSK Canada’s new head office coincidences with the unveiling on June 9, 2022, of the company’s revamped branding, reflecting its new purpose—uniting …See details»
GSK NEXT - Investments, Portfolio & Company Exits - Crunchbase
Jul 20, 2022 GSK NEXT has made 8 investments. Their most recent investment was on Jul 20, 2022, when Dianox raised GSK NEXT has made 3 diversity investments. Their most recent …See details»
GSK - Crunchbase Company Profile & Funding
GSK manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. ... Which industries do these Sub-Organization operate in? Show . GSK NEXT Investment Arm. Frequently Asked Questions. Edit …See details»
New GSK to deliver step-change in growth and performance over …
Jun 23, 2021 At an update to investors today, GlaxoSmithKline plc (GSK LSE & NYSE) will provide details of its strategy, outlook for growth and plans to create shareholder value, …See details»
At GSK, we unite science,
Health Organization (WHO) diseases reduction in operational carbon emissions (Scope 1 and 2) Culture Culture progress – ambitious for patients, accountable for impact and do the right thing …See details»
GSK breaks up with BIO for 2025 - fiercepharma.com
Nov 8, 2024 GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies …See details»
Purpose, strategy and culture - GSK
We are a world leader in next-generation HIV treatment and prevention, through ViiV Healthcare, the world’s only specialist HIV pharmaceutical company, which we majority own.See details»
GSK Canada unveils new head office, embracing a hybrid
Jun 15, 2022 GSK aims to impact the health of 2.5 billion people over the next 10 years. To achieve the company's bold ambitions for patients, GSK is committed to be a company where …See details»
Innovation | GSK Canada
GlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1 > GSK Modern Slavery Act Statement 2023 (PDF - 154.2KB) GSK websitesSee details»
Governance - GSK
Our corporate governance architecture is designed to enhance the effectiveness of our Board and support their oversight of the GSK Leadership Team (GLT) in delivering our Ahead Together …See details»
GSK and CureVac to develop next generation mRNA COVID-19 …
Feb 3, 2021 Emma Walmsley, Chief Executive Officer, GSK, said: “We believe that next generation vaccines will be crucial in the continued fight against COVID-19. This new …See details»
23 JUNE 2021 New GSK: new ambitions shareholders
Jun 23, 2021 New GSK: new ambitions for patients and shareholders. Cautionary statement regarding ... More than 5% sales and 10% adjusted operating profit CAGR expected in next 5 …See details»
Responsibility | GSK Canada
Our plan shows that we can positively impact the health of 2.5 billion people worldwide over the next 10 years. Acting as a responsible business by considering our social, environmental and …See details»
Company | GSK
GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act statement 2023 (PDF - …See details»